Tenet Healthcare stock has delivered very strong gains over the past three years, yet the current valuation checks still suggest the shares lean cheap rather than stretched.

• Tenet Healthcare has returned 271.8% over the past three years, which puts extra focus on whether recent gains already reflect its fundamentals.
• Stronger profitability and revenue growth expectations can support the current share price, while any setback in margins or volumes may quickly challenge the recent rerating.
• The broader checks point to value, with Tenet Healthcare screening as undervalued in 5 of 6 valuation metrics, which suggests the current price still embeds some caution.

The issue now is whether Tenet Healthcare's recent share price strength already reflects these improving trends or still leaves room for further upside in the valuation.

Does Tenet Healthcare Look Undervalued on Earnings?

The P/E multiple is a useful yardstick for Tenet Healthcare because earnings are a key driver of how investors tend to value hospital operators and related healthcare services companies.

Tenet Healthcare trades on a P/E of 9.7x, which sits well below the wider healthcare sector average of 25.0x and also under the peer group average of 20.1x. The model based fair P/E ratio for Tenet Healthcare is 17.9x, which reflects what might be expected given its size, profitability profile and sector risks. This indicates that the current earnings multiple is at a sizeable discount to the level suggested by that framework.

Because the company recently reported stronger adjusted earnings in its fiscal Q2 2026 update and raised its full year 2026 outlook, this comparatively low P/E indicates that the stock is not being priced in line with that earnings picture.

On the P/E multiple, Tenet Healthcare stock currently appears undervalued relative to both its tailored fair value estimate and sector benchmarks.

The Tenet Healthcare Narrative: What Would Justify Today's Price?

Simply Wall St Narratives take this P/E puzzle for Tenet Healthcare and turn it into clear, quantified stories about what would need to happen to growth, margins and earnings for the stock to be worth materially more or less than today’s price. These narratives sit on the company’s Community page. Each narrative links its number to a specific view on how Tenet Healthcare's growth, profitability and risks might evolve, giving you something concrete to revisit as fresh results and guidance arrive.

One of the top community narratives on Tenet Healthcare: 12% overvalued

"Tenet Healthcare is no longer just a hospital operator. It is evolving into a broader healthcare platform built around efficiency, integration, and long-term patient management."

Do you think there's more to the story for Tenet Healthcare? Head over to our Community to see what others are saying!

The Bottom Line

For investors looking at Tenet Healthcare today, the valuation still leans towards undervalued on the market multiples that matter most, especially the P/E. The key question is whether the current margin and volume profile can be sustained so that earnings continue to back up that discount. If profitability or demand softens, the gap to sector and peer valuations may close without further upside. The crux of the debate from here is whether Tenet Healthcare keeps delivering on earnings power, which would help the market maintain or reassess the current pricing.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.